About
- - Company
    - About Sensus Healthcare
    - Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for both oncological and non-oncological conditions.
      
      Read More
  - Patient Advocates
  - FAQ
    - - What is SRT?
        We offer a painless, safe and highly effective non-surgical skin cancer treatment that is an alternative to surgery—Superficial Radiation Therapy using the SRT-100™.
        
        Go to FAQ
      - What does SRT treat?
        The SRT-100™ is an excellent treatment option for patients with the following conditions: Keloid scars, Basal cell carcinoma, Squamous cell carcinoma, Metatypical carcinoma, Cutaneous appendage carcinoma, Actinic keratosis, Kaposi’s sarcoma.
        
        Go to FAQ
      - Is SRT right for me?
        The SRT-100™ doesn’t harm surrounding or underlying healthy tissue while targeting cancer cells. The SRT-100™ provides excellent cosmetic outcomes and is a great alternative for patients with various co-morbidities.
        
        Go to FAQ
      - What should I expect?
        You should expect the same results as surgery, but with these additional benefits: No pain, No anesthesia, No cutting, No bleeding, No stitching, No scarring, No interruption of lifestyle, No reconstructive surgery
        
        Go to FAQ
      - Is the SRT-100 safe?
        The SRT-100™ is a safe and proven technology that effectively treats non-melanoma skin cancers, keloid scarring, actinic keratosis and Kaposi’s sarcoma. It is utilized by dermatologists and radiation oncologists all over the world because it delivers good patient outcomes.
        
        Go to FAQ
  - Careers
    - - Sensus - Field Service Engineer
    - View Career Opportunities
Physicians
Patients
Investors
- Corporate Governance Guidelines
- Code of Ethics and Business Conduct
Resources
Contact Us

Report on Inner Arm excess skin relaxation treatment through Dermoelectroporation

Dr. A.Gessati,
Aesthetic medicine Doctor, Milan, Italy.

Preliminary Study

Dermoelectroporation, well known and established method for transdermal substances delivery without the use of needles, allows to get to important results for skin imperfection conditions, such as the inner arm areas relaxation (with the formation of bands of tissue in excess), which are often solved only through surgical methods. The correction of excessively relaxed skin, related to the loss of elastic features and support, requires biorevitalizing substances transdermal delivery(REVITALASE) commonly injected through a syringe, due to Ultrapeel Transderm Meso system device endorsing Dermoelectroporation technology. We developed an operating protocol Synergyzing the effect of biostimulanting substances driven through the skin with LED device(OMNILUX REVIVE 633 nm) able to to affect the cellular response.

Study Design

5 patients were treated to follow-up every week.
Revitalase from Mattioli engineering -Italy)
Ultrapeel® Transderm® Meso System
Weekly Session (depending on the single patient's condition) for a total of 5 to 8 sessions.
20mins application each session (AVG).
Treated areas: Hips, legs and abdomen.

Materials and Methods

Materials

Revitalase (Mattioli engineering)
Ultrapeel® Transderm® Meso System(Mattioli engineering)

Methods

Pre-Sterilised corundum crystals Microdermabrasion up to reach a strong hyperemia.
Transdermal delivery of REVITALASE – (Hyaluronic acid enriched by Tissue growth factors)
Red LED Photo-biomodulation 633+/-6 nm.
1 session per week for a total of 5-8 sessions depending on the single patient.